428 related articles for article (PubMed ID: 18185485)
1. Investing in oncology biotech stocks.
Feuerstein A
Clin Adv Hematol Oncol; 2007 Nov; 5(11):879-80. PubMed ID: 18185485
[No Abstract] [Full Text] [Related]
2. BIO 2006 Annual International Convention. The expanding biotech industry of France.
Zarkowska T
IDrugs; 2006 Jun; 9(6):383-5. PubMed ID: 16752302
[No Abstract] [Full Text] [Related]
3. Placing bets on biotech.
Weintraub K
Cancer Discov; 2011 Nov; 1(6):462. PubMed ID: 22586641
[No Abstract] [Full Text] [Related]
4. Deal-making trends in oncology.
Moore K; Walker J
Nat Rev Drug Discov; 2009 Aug; 8(8):604. PubMed ID: 19644466
[No Abstract] [Full Text] [Related]
5. Cancer pathways' target not validated by clinical results.
Ratner M
Nat Biotechnol; 1999 Mar; 17(3):220. PubMed ID: 10096279
[No Abstract] [Full Text] [Related]
6. How Genentech got it.
Stipp D
Fortune; 2003 Jun; 147(11):81-2, 84, 86 passim. PubMed ID: 12800575
[No Abstract] [Full Text] [Related]
7. Biotech bonanza.
Stipp D
Fortune; 1999 Nov; 140(9):333-4. PubMed ID: 10623111
[No Abstract] [Full Text] [Related]
8. The drug that could have been.
Schultz S
US News World Rep; 2002 Aug; 133(7):18, 20-3. PubMed ID: 12195678
[No Abstract] [Full Text] [Related]
9. Nasdaq restructures biotech index.
Morrison C
Nat Biotechnol; 2001 Mar; 19(3):187. PubMed ID: 11231518
[No Abstract] [Full Text] [Related]
10. Stocks' study renews concerns over insider trading on oncology drugs.
Goozner M
J Natl Cancer Inst; 2011 Nov; 103(22):1652-5. PubMed ID: 22025626
[No Abstract] [Full Text] [Related]
11. How the street sees biotech.
Lashinsky A
Fortune; 2003 Jun; 147(11):86. PubMed ID: 12800576
[No Abstract] [Full Text] [Related]
12. Biotech companies adapt to big pharma mergers.
Niiler E
Nat Biotechnol; 2000 May; 18(5):487-8. PubMed ID: 10802607
[No Abstract] [Full Text] [Related]
13. Public biotech 98: the numbers.
Lähteenmäki R; Michael A; Marshall A
Nat Biotechnol; 1999 May; 17(5):429-32. PubMed ID: 10331795
[No Abstract] [Full Text] [Related]
14. Can personalized drugs pay off?
Stipp D
Fortune; 2002 May; 145(10):168. PubMed ID: 12025349
[No Abstract] [Full Text] [Related]
15. Biotech slumps in Q1.
Lawrence S
Nat Biotechnol; 2008 May; 26(5):486. PubMed ID: 18464769
[No Abstract] [Full Text] [Related]
16. BioXell: an Italian biotech success story?
Sheridan C
Nat Biotechnol; 2006 Sep; 24(9):1045-6. PubMed ID: 16964198
[No Abstract] [Full Text] [Related]
17. PEGging biotech growth.
Jacobs T
Nat Biotechnol; 2006 May; 24(5):506. PubMed ID: 16680127
[No Abstract] [Full Text] [Related]
18. A special biotech speculation.
Jacobs T
Nat Biotechnol; 2006 Jun; 24(6):622. PubMed ID: 16763586
[No Abstract] [Full Text] [Related]
19. How changes in drug-safety regulations affect the way drug and biotech companies invest in innovation.
Reed SD; Califf RM; Schulman KA
Health Aff (Millwood); 2006; 25(5):1309-17. PubMed ID: 16966727
[TBL] [Abstract][Full Text] [Related]
20. Biotech R&D goes further afield.
Lawrence S
Nat Biotechnol; 2006 Sep; 24(9):1052. PubMed ID: 16964201
[No Abstract] [Full Text] [Related]
[Next] [New Search]
